Detalhe da pesquisa
1.
Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function.
J Hepatol
; 76(1): 11-24, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34555423
2.
Hypoxia-inducible factor 2α drives hepatosteatosis through the fatty acid translocase CD36.
Liver Int
; 40(10): 2553-2567, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32432822
3.
Angiopoietin-Like Protein 8 Is a Novel Vitamin D Receptor Target Gene Involved in Nonalcoholic Fatty Liver Pathogenesis.
Am J Pathol
; 188(12): 2800-2810, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30248338
4.
Inhibition of ALK3-mediated signalling pathway protects against acetaminophen-induced liver injury.
Redox Biol
; 71: 103088, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38401290
5.
Circulating bone morphogenetic protein 8A is a novel biomarker to predict advanced liver fibrosis.
Biomark Res
; 11(1): 46, 2023 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37106416
6.
Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool.
Biomark Res
; 10(1): 35, 2022 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35614516
7.
Intrahepatic Expression of Fatty Acid Translocase CD36 Is Increased in Obstructive Sleep Apnea.
Front Med (Lausanne)
; 7: 450, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32850919
8.
Insulin receptor substrate 2 (IRS2) deficiency delays liver fibrosis associated with cholestatic injury.
Dis Model Mech
; 12(7)2019 07 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31262748
9.
Sofosbuvir improves HCV-induced insulin resistance by blocking IRS1 degradation.
Clin Transl Med
; 11(1): e275, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33463051